271 related articles for article (PubMed ID: 6584630)
21. Prostaglandin E2 suppositories as a second-trimester abortifacient.
Rakhshani R; Grimes DA
J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
[TBL] [Abstract][Full Text] [Related]
22. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
Hagar DL; Valley MT; Rayburn WF; Carey JC
J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
[TBL] [Abstract][Full Text] [Related]
23. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
Ramsey PS; Savage K; Lincoln T; Owen J
Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
[TBL] [Abstract][Full Text] [Related]
24. Management of uterine hyperstimulation after prostaglandin E2 administration.
Goyert GL; Mariona FG
Obstet Gynecol; 1987 Sep; 70(3 Pt 2):468-70. PubMed ID: 3476877
[TBL] [Abstract][Full Text] [Related]
25. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
Scher J; Jeng DY; Moshirpur J; Kerenyi TD
Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
[TBL] [Abstract][Full Text] [Related]
26. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
Kirz DS; Haag MK
Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
[TBL] [Abstract][Full Text] [Related]
27. Experience with prostaglandin E2 in obstetric practice.
Mehta A; Popat N
J Obstet Gynaecol India; 1974 Dec; 24(6):533-44. PubMed ID: 12311296
[TBL] [Abstract][Full Text] [Related]
28. [Intracervical prostaglandin E2 as pre-inducer of labor in patients with preterm fetal death].
Garcia-B CQ; Baez-Vasquez B; Rodriguez-Colorado S
Ginecol Obstet Mex; 1996 Jan; 64():21-5. PubMed ID: 8948920
[TBL] [Abstract][Full Text] [Related]
29. Induction of labor in patients with missed abortion and fetal death in utero with protaglandin E2 suppositories.
Lauersen NH; Wilson KH
Am J Obstet Gynecol; 1977 Mar; 127(6):609-11. PubMed ID: 557289
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of uterine activity after vaginal administration of prostaglandins.
Henzl MR; Arvealo TN; Noriega L; Aznar R; Ortega E; Segre E
Adv Biosci; 1973; 9():767-72. PubMed ID: 4805889
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet.
Rabl M; Joura EA; Yücel Y; Egarter C
J Reprod Med; 2002 Feb; 47(2):115-9. PubMed ID: 11883349
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2 vaginal suppositories for therapeutic abortion.
Newman C; Bailey CD; Ellinas SP; Anderson GG
Adv Plan Parent; 1975; 10(1):34-8. PubMed ID: 1164986
[No Abstract] [Full Text] [Related]
33. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise.
Debby A; Sagiv R; Girtler O; Sadan O; Glezerman M; Golan A
Arch Gynecol Obstet; 2003 Oct; 268(4):301-3. PubMed ID: 14504874
[TBL] [Abstract][Full Text] [Related]
34. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion.
Bailey CD; Newman C; Ellinas SP; Anderson GG
Obstet Gynecol; 1975 Jan; 45(1):110-3. PubMed ID: 1110809
[TBL] [Abstract][Full Text] [Related]
35. Treatment of postpartum uterine atony with prostaglandin E2 vaginal suppositories.
Hertz RH; Sokol RJ; Dierker LJ
Obstet Gynecol; 1980 Jul; 56(1):129-30. PubMed ID: 6966776
[TBL] [Abstract][Full Text] [Related]
36. [Induction of labor. A double-blind randomized study of prostaglandin E2 vaginal suppositories compared with intranasal oxytocin].
Larsen J; Andreasson B; Bock JE
Ugeskr Laeger; 1983 Aug; 145(34):2588-90. PubMed ID: 6351397
[No Abstract] [Full Text] [Related]
37. Uterine rupture associated with the use of vaginal prostaglandin E2 suppositories.
Keller F; Joyce TH
Can Anaesth Soc J; 1984 Jan; 31(1):80-2. PubMed ID: 6581851
[TBL] [Abstract][Full Text] [Related]
38. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
Robins J; Surrago EJ
J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
[TBL] [Abstract][Full Text] [Related]
39. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
Hochman M; Laufe LE
J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
[TBL] [Abstract][Full Text] [Related]
40. Intravenous prostaglandin E2 and 16-phenoxy prostaglandin E2 methyl sulfonylamide for induction of fetal death in utero.
Gruber WS; Baumgarten K
Am J Obstet Gynecol; 1980 May; 137(1):8-14. PubMed ID: 7369292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
